AstraZeneca (AZN) Health Care Sector

  • Latest quote

    5,875.00p (mid)

  • Current Change (%)

    -0.15%

  • Price

    Bid: 5,871.00p

    Offer: 5,872.00p

  • Today

    High: 5,906.00p

    Low: 5,830.97p

  • This year

    High: 6,525.00p

    Low: 5,182.00p

  • Information

    Volume: 737,927

    Market Cap: £77021.25M



AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

AstraZeneca RNS Feed

Title Release date
Pooled analyses of the roxadustat global Phase III 07:00 - May 10, 2019
Director/PDMR Shareholding 14:00 - May 8, 2019
Director Declaration 11:00 - May 8, 2019
Trastuzumab deruxtecan demonstrated clinically 07:00 - May 8, 2019
Qternmet XR approved in the US for type-2 diabetes 07:00 - May 3, 2019
Total Voting Rights 15:00 - May 1, 2019
Director/PDMR Shareholding 12:00 - May 1, 2019
Lynparza receives positive EU CHMP opinion for 1st 07:00 - April 29, 2019
Result of AGM 17:45 - April 26, 2019
AZN: Q1 2019 Results 07:00 - April 26, 2019
Lynparza approved in EU for the treatment of germl 07:00 - April 10, 2019
Holding(s) in Company 13:30 - April 4, 2019
Director/PDMR Shareholding 10:00 - April 3, 2019
Total Voting Rights 15:00 - April 2, 2019
Astrazeneca 18:00 - April 1, 2019

NOTE: This is based on 232 open tips for this company


Total Number of Share tips :

468

View all AstraZeneca Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today